Doutor Nichires Holdings Co., Ltd. (3087) AI Stock Analysis

• Market Cap: ¥110.59B
• Dividend Yield: 2.16%
• Average Volume (3M): 126.76K
• Price to Earnings (P/E): 16.4
• Beta (1Y): 0.29
• Revenue Growth: 5.78%
• EPS Growth: 10.26%
• Country: JP
• Employees: 2,765
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Restaurants
• EPS (TTM): 44.24
• Shares Outstanding: 45,609,760
• 10 Day Avg. Volume: 95,670
• 30 Day Avg. Volume: 126,763
• PEG Ratio: 0.59
• Price to Book (P/B): 1.01
• Price to Sales (P/S): 0.70
• P/FCF Ratio: 16.14
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 26,676.54
• Revenue Forecast (FY): ¥24.66T

• Rating: 70 Outperform
• Price Target: ¥2,796.00 ▲(9.56% Upside)

Doutor Nichires Holdings Co., Ltd. receives a strong overall stock score driven primarily by its robust financial performance, including solid revenue growth and a strong balance sheet. Technical analysis presents mixed signals, with short-term weakness but long-term support, while valuation indicates the stock is fairly priced with a moderate dividend yield.

Positive Factors

Revenue Growth

The consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term financial stability.

Cash Flow Generation

Robust cash flow generation allows for reinvestment in the business and potential shareholder returns, enhancing long-term value.

Balance Sheet Strength

A strong balance sheet with low leverage reduces financial risk and provides flexibility for future growth opportunities.

Negative Factors

Profitability Challenges

Challenges in maintaining profitability could impact long-term financial health and limit resources for growth and innovation.

Operational Efficiency

While margins have improved, ongoing efficiency improvements are crucial to sustain profitability amidst competitive pressures.

Market Competition

Modest growth forecasts suggest potential competitive pressures, which may require strategic adjustments to maintain market position.

Doutor Nichires Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Doutor Nichires Holdings Co., Ltd. (3087) is a prominent Japanese company primarily engaged in the food and beverage sector. The company operates a network of coffee shops and restaurants, primarily under the Doutor Coffee brand, which is well-known for its high-quality coffee and light meals. In addition to its retail operations, Doutor Nichires also engages in the wholesale distribution of coffee and related products, catering to both domestic and international markets. The company focuses on providing a unique customer experience through its diverse offerings and a commitment to quality.

How the Company Makes Money

Doutor Nichires Holdings generates revenue primarily through its coffee shop and restaurant operations, where it sells a variety of coffee drinks, light meals, and snacks. The company's revenue model includes direct sales from retail locations, where customers pay for products and services. Additionally, Doutor Nichires earns revenue from the wholesale distribution of coffee beans and related products to other businesses, including restaurants, hotels, and retail outlets. Partnerships with suppliers and distributors enhance its market reach and product availability. Furthermore, the company may benefit from franchise operations, allowing it to expand its brand presence with reduced capital investment. Seasonal promotions and marketing strategies also contribute to increasing sales during peak times.

Doutor Nichires Holdings Co., Ltd. Financial Statement Overview

Summary

Doutor Nichires Holdings Co., Ltd. exhibits a strong financial performance with solid revenue growth, improved profit margins, and robust cash flow metrics. The balance sheet is strong with low leverage, indicating prudent financial management and a positive outlook for continued success.

Income Statement

Doutor Nichires Holdings Co., Ltd. has demonstrated strong revenue growth over the past years, with a notable recovery from past losses. The company's gross and net profit margins have improved significantly in recent years, reflecting effective cost management and increased efficiency. The EBIT and EBITDA margins have also shown positive trends, indicating robust operational performance.

Balance Sheet

The company maintains a strong financial position with a low debt-to-equity ratio, reflecting prudent financial management and low leverage risk. The equity ratio indicates a solid capital structure with substantial shareholder equity backing the company's assets. The return on equity has improved, showcasing enhanced profitability and efficient use of equity capital.

Cash Flow

Doutor Nichires Holdings has consistently generated positive operating cash flows, which have supported its investment activities and capital expenditures. The free cash flow growth rate is strong, suggesting healthy cash generation and potential for reinvestment or shareholder returns. The operating cash flow to net income ratio reflects a robust cash conversion cycle.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	151.23B	148.82B	140.63B	126.86B	109.36B	96.14B
Gross Profit	90.45B	89.62B	84.19B	74.77B	64.31B	55.77B
EBITDA	13.82B	13.94B	11.72B	6.88B	7.63B	-4.40B
Net Income	6.58B	6.88B	5.49B	3.43B	1.22B	-10.98B
Balance Sheet
Total Assets	133.54B	134.23B	127.79B	121.04B	118.23B	115.25B
Cash, Cash Equivalents and Short-Term Investments	33.34B	38.99B	35.80B	32.22B	34.55B	26.31B
Total Debt	2.04B	2.11B	2.40B	1.71B	1.54B	1.31B
Total Liabilities	32.33B	29.88B	28.32B	24.75B	24.12B	21.25B
Stockholders Equity	100.86B	104.00B	99.15B	96.01B	93.86B	93.78B
Cash Flow
Free Cash Flow	0.00	6.49B	6.87B	-221.00M	10.22B	-8.06B
Operating Cash Flow	0.00	12.35B	11.79B	5.17B	14.64B	-2.88B
Investing Cash Flow	0.00	-6.23B	-4.90B	-5.59B	-4.93B	-5.95B
Financing Cash Flow	0.00	-2.93B	-3.37B	-1.98B	-1.50B	-2.15B

Doutor Nichires Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2552.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3087, the sentiment is Positive. The current price of 2552 is above the 20-day moving average (MA) of 2443.70, above the 50-day MA of 2532.82, and above the 200-day MA of 2524.43, indicating a bullish trend. The MACD of -1.05 indicates Negative momentum. The RSI at 62.64 is Neutral, neither overbought nor oversold. The STOCH value of 93.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3087.

Doutor Nichires Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3087	70 Outperform	¥110.59B	16.37	―	2.16%	5.78%	10.26%
8153	70 Outperform	¥120.56B	34.01	―	0.76%	5.15%	47.13%
2695	66 Neutral	¥128.49B	57.33	―	0.60%	5.43%	-62.27%
7630	66 Neutral	¥148.44B	49.45	―	1.71%	9.51%	6.29%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
9887	57 Neutral	¥111.10B	40.92	―	0.41%	20.44%	13.71%
7412	41 Neutral	¥106.59B	151.49	―	―	-12.01%	―

Doutor Nichires Holdings Co., Ltd. Corporate Events

Doutor Nichires Holdings Reports Mixed Financial Results for H1 2025

Doutor Nichires Holdings Co., Ltd. reported consolidated financial results for the six months ended August 31, 2025, showing a 5.9% increase in net sales compared to the previous year. However, the company experienced a decline in operating and ordinary profits, with a notable decrease in profit attributable to owners of the parent. Despite these challenges, the company maintains a strong equity-to-asset ratio and plans to increase its annual dividends per share for the fiscal year ending February 28, 2026, indicating confidence in future performance.

The most recent analyst rating on (JP:3087) stock is a Buy with a Yen2796.00 price target. To see the full list of analyst forecasts on Doutor Nichires Holdings Co., Ltd. stock, see the JP:3087 Stock Forecast page.